Fresenius Medical Care Surges 10% Revenue, 28% Income Growth — What It Means for Investors
Fresenius Medical Care’s Q3 2025 earnings reveal 28% income growth, margin expansion to 11.7%, and a cost‑saving push—yet stock volatility remains high amid U.S. market uncertainties.
4 minutes to read